Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2021-07-13 00:00:00 ET · period of report 2021-07-12 · accession 0001209191-21-046589 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-13 | 2021-07-12 | KPTI | Shah Jatin | EVP, Chief Medical Off | F - Tax | $9.73 | -665 | 131.1K | -0.5% | -$6,470 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-12 | F | D | 665 | $9.73 | 131,137 | D | — | — | (F1) Represents shares withheld to satisfy the reporting person's tax obligation in connection with the vesting of 2,413 restricted stock units on July 11, 2021. |